School personnel information


Sawada Kenjiro


Ovarian Cancer and Peritoneal Dissemination

Mail Address

Mail Address



Organization 【 display / non-display

  • 2007.05.01 - 2012.08.31, Osaka University Hospital, Assistant Professor

  • 2012.09.01 - , Graduate School of Medicine, Associate Professor

Education 【 display / non-display

Osaka University Faculty of Medicine  Graduated 1995.03
Osaka University Graduate School, Division of Medical Sciences  Completed 2002.10

Employment Record 【 display / non-display

Osaka Univeresity Graduate School of Medicine Dept. of OB/GYN Assistant Professor 2007.04 - 2012.08

Research topics 【 display / non-display

  • Osteoporosis

  • Ovarian Cancer


Academic Papers 【 display / non-display

  • Direct oral anticoagulants are effective and safe for the treatment of venous thromboembolism associated with gynecological cancers., Shimizu A, Sawada K, Shiomi M, Kawano M, Matsumoto Y, Takiuchi T, Kodama M, Kobayashi E, Hashimoto K, Mabuchi S, Ueda Y, Tomimatsu T, Kimura T, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,147(2) 252-257, 2019.11, Papers

  • Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells, Yoshimura, A. Sawada, K. Nakamura, K. Kinose, Y. Nakatsuka, E. Kobayashi, M. Miyamoto, M. Ishida, K. Matsumoto, Y. Kodama, M. Hashimoto, K. Mabuchi, S. Kimura, T., BMC Cancer,18:1065, 2018.11, Papers

  • Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer., Yokoi E, Mabuchi S, Shimura K, Komura N, Kozasa K, Kuroda H, Takahashi R, Sasano T, Kawano M, Matsumoto Y, Kodama M, Hashimoto K, Sawada K, Kimura T., Invest New Drugs,Epub ahead of print, 2018.10, Papers

  • A phase I/II study of GLIF combination chemotherapy for taxane/platinum-refractory/resistant endometrial cancer (GOGO-EM2), Tanaka, Y. Ueda, Y. Nakagawa, S. Matsuzaki, S. Kobayashi, E. Shiki, Y. Nishio, Y. Takemura, M. Yamamoto, T. Sawada, K. Tomimatsu, T. Yoshino, K. Kimura, T., Cancer Chemother Pharmacol,82:585-592, 2018.10, Papers

  • Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer, Kuroda, H. Mabuchi, S. Yokoi, E. Komura, N. Kozasa, K. Matsumoto, Y. Kawano, M. Takahashi, R. Sasano, T. Shimura, K. Kodama, M. Hashimoto, K. Sawada, K. Morii, E. Kimura, T., Oncotarget, 9:36317-36330, 2018.09, Papers

display all >>